US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Bausch + Lomb Corporation

< Previous 1 2 3 4 Next >
News headline image
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Releases 2025 Sustainability Impact Report
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
News headline image
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
From Bausch + Lomb Corporation
Via Business Wire
Tickers BLCO TSX:BLCO
< Previous 1 2 3 4 Next >